Neurol. praxi. 2021;22(4):274-277 | DOI: 10.36290/neu.2021.012

Lyme neuroborreliosis

doc. MUDr. Lenka Krbková, CSc.
Klinika dětských infekčních nemocí, Fakultní nemocnice a Lékařská fakulta MU Brno

Lyme borreliosis is multisystemic disease, caused by a Lyme borrelia from a serocomplex of Borrelia burgdorferi sensu lato. The main vector of borreliae in Europe is Ixodes ricinus. All stages of a tick (larvae, nymphae and adults) play a role in the transmission of the disease. Two borrelial species seem to be the most neurotropic: B. garinii and B. bavariensis. Lyme neuroborreliosis (LNB) is an acute involvement of central and peripheral nervous system which develops usually within a few weeks after a tick-bite. The disease presents as painful meningoradiculoneuritis in adults or as meningoneuritis in children. Cranial neuritis such as unilateral or bilateral facial palsy is the most typical manifestation. Examination of cerebrospinal fluid shows a lymphocytic pleocytosis with evidence of intrathecal production af antibodies to borreliae. Parenteral antibiotic treatment is recommended for LNB.

Keywords: lyme neuroborreliosis, borrelia burgdorferi, facial palsy, intrathecal synthesis.

Received: February 12, 2021; Revised: February 22, 2021; Accepted: February 22, 2021; Published: September 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krbková L. Lyme neuroborreliosis. Neurol. praxi. 2021;22(4):274-277. doi: 10.36290/neu.2021.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V, Blaison G, Hansmann Y, Christmann D, Tranchant C. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007; 69(10): 953-958. Go to original source... Go to PubMed...
    2. Coipan EC, Jahfari S, Fonville M, Oei GA, Spanjaard L, Hovius JWR, Sprong H. Inbalanced presence of Borrelia burgdorferi s.l. multilocus sequence types in clinical manifestations of Lyme borreliosis. Infect Genet Evol 2016; 42: 66-76. Go to original source... Go to PubMed...
    3. Feder HM, Johnson BJB, O´Connel S, Shapiro ED, Steere AC, Wormser GP. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007; 357: 1422-1430. Go to original source... Go to PubMed...
    4. Halperin JJ. Neuroborreliosis J Neurol 2017;264(6):1292-1297 Go to original source... Go to PubMed...
    5. Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 69(1): 91-102. Go to original source... Go to PubMed...
    6. Krbková L, Kybicová K, Pícha D, Roháčová H, Smíšková D. Doporučený postup diagnostiky a léčby lymeské borreliózy. Klin Mikrobiol Inf Lék 2018; 24(3): 88-99.
    7. Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 2007; 14(8): 873-876. Go to original source... Go to PubMed...
    8. Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicenter, non-inferiority, double-blind, randomized trial. Lancet Neurol 2008; 7: 690-695. Go to original source... Go to PubMed...
    9. Mygland A, Ljostad U, Fingerle V, Rupprecht I, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16. Go to original source... Go to PubMed...
    10. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol 2006; 13: 1213-1215. Go to original source... Go to PubMed...
    11. Ornstein K, Berglund J, Bergstrom S, Norrby R, Barbour A. Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden. Scand J Infect Dis 2002; 34(5): 341-346. Go to original source... Go to PubMed...
    12. Reiber H, Ressel CB, Apreer A. Diagnosis of neuroborreliosis - Improved knowledge base for qualified antibody analysis and cerebrospinal fluid data pattern related interpretations. Neurol Psych Brain Res 2013; 10: 159-169. Go to original source...
    13. Roberts ED, Bohm RP Jr, Lowrie RC Jr, Habicht G, Katona L, Piesman J, Philipp MT. Pathogenesis of Lyme neuroborreliosis in the Rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998; 178(3): 722-732. Go to original source... Go to PubMed...
    14. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. The chemokine CXCL13 (BLC): A putative marker for neuroborreliosis. Neurology 2005; 65: 448-450. Go to original source... Go to PubMed...
    15. Stanek G, Fingerle V, Hunfeld K-P, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O´Connel S, Ornstein K, Strle F, Gray J. Lyme borreliosis: Clinical case definition for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17: 79-79. Go to original source... Go to PubMed...
    16. Stanek G, Reiter M. The expanding Lyme Borrelia complex - clinical significance of genomic species? Clin Microbiol Infect 2011; 17: 487-493. Go to original source... Go to PubMed...
    17. Strle F, Stanek G. Clinical manifestations and diagnosis of Lyme Borreliosis. Curr Probl Dermatol 2009; 37: 51-110. Go to original source... Go to PubMed...
    18. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport JM, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A,Stewart K, Daly F. Early treatment with prednisolone or acyclovir in Bell´s palsy. N Eng J Med 2007; 357(16): 1598-607. Go to original source... Go to PubMed...
    19. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49(1): 13-21. Go to original source... Go to PubMed...
    20. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis 2006; 43: 1089-1134. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.